David Benigson is CEO of Signal AI, a company using AI and media data to help executives cut through noise and drive actionable insights. Risk is no longer a four-letter word—it's a critical factor ...
The US Food and Drug Administration (FDA) on Tuesday issued final guidance meant to assist drug and medical device makers in developing risk-based monitoring strategies for clinical investigations ...
The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...
This post is sponsored by IMARC Research, Inc. Since the August 2011 release of the draft guidance document by the FDA on a risk-based approach to monitoring, there has been a lot of buzz in the ...
Portfolio risk management tools are an essential part of your firm's tech stack. These platforms help you spot risks, compare exposures, and adjust portfolios to match each client's risk tolerance and ...
US and EU officials explained on Wednesday what their respective regulatory agencies look for in clinical trial risk-based monitoring (RBM) and how RBM can impact review times. Under a cooperative ...
NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Dow Jones Risk & Compliance has today announced a new advanced, AI-powered solution for financial crime and third-party risk management. RiskCenter ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...
ChainIT and RS Software today announced a product alliance to bring risk-based authentication to account-to-account (A2A) ...
Monitoring AI agents in production is a fundamentally different problem from monitoring traditional software or even ...
Fraud in payments is growing more sophisticated, forcing payment service providers (PSPs) to rethink their defenses. Today’s fraudsters are even leveraging AI tools to scale attacks and evade ...